DHX9 and cancer: When comparing the expression levels of the helicases across normal tissue and tumors, recovered from the GENT database [52], we found that DHX36 displayed altered expression levels in eight and DHX9 in nine out of 15 types of cancers analyzed (Additional file 1: Figure S14b and c).